Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20230127057244N3Phase 3Completed
Phase 3, double-blind trial of platelet-rich plasma in rhinosinusitis and chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Improvement of olfaction. Started Jan 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20230127057244N3.